The guidance describes the information you should document at the manufacturing facility and include in any premarket submissions. It is intended to help medical device manufacturers identify the possible risks related to tissues from animal sources when these tissues are used in medical devices.
More Articles on Supply Chain:
Medline Launches New Products Catalog
Boston Scientific Looks to Expand Chinese Presence
Supply Chain Efficiency Improved With Inventory Management Intervention
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
